Skip to main content
. 2016 Feb 1;7(9):9707–9717. doi: 10.18632/oncotarget.7110

Figure 1. List of altered genes.

Figure 1

Overall, 211/238 (89%) alterations were mutations and 27/238 (11%) were amplifications. Of 29 patients with EGFR alterations, 11 (38%) had an EGFR amplification only; two (7%), both an EGFR amplification and EGFR mutation(s); and 16 (55%) had EGFR mutation(s) only. Of eight patients with ERBB2 anomalies, two (25%) had an ERBB2 amplification only; two (25%), both an ERBB2 amplification and ERBB2 mutation(s); and four (50%), only an ERBB2 mutation. Of 18 patients with a MET aberration, 10 (56%) had a MET amplification only (10/18=56%) and eight (44%), a MET mutation only.